What happened
TKG Huchems disclosed an acquisition of AprilBio, worth US$97M.
For context, this deal is worth about 12.8% of the company's own total assets.
| Target | AprilBio |
|---|---|
| Deal value | US$97M |
| vs. company assets | 12.8% |
| Filed | 2026-06-25, Decision to acquire shares/equity in another company |
| Source | DART rcept 20260625800003 → open original filing |
Source: DART. Information only, not investment advice.